托吡卡胺雜質(zhì)Ⅰ [N-(4-吡啶甲基)乙胺]
|
PCL-#-Chp0112-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
33403-97-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅱ去氫灰黃霉素((1'S)-7氯2'4,6-三甲氧基-6'甲基嫘[苯并呋喃-2(3H),1'[2,5]環(huán)己二烯]-3,4'-二酮)
|
PCL-#-Chp0111-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
3573-90-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅱ去氫灰黃霉素((1'S)-7氯2'4,6-三甲氧基-6'甲基嫘[苯并呋喃-2(3H),1'[2,5]環(huán)己二烯]-3,4'-二酮)
|
PCL-#-Chp0111-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
3573-90-8 |
25mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅰ 去氯灰黃霉素((1'S,6'R))-2',4,6-三甲氧基-6'-甲基螺[苯并呋喃-2(3H),1'-[2]環(huán)己烯]-3,4'-二酮)
|
PCL-#-Chp0110-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
3680-32-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
灰黃霉素雜質(zhì)Ⅰ 去氯灰黃霉素((1'S,6'R))-2',4,6-三甲氧基-6'-甲基螺[苯并呋喃-2(3H),1'-[2]環(huán)己烯]-3,4'-二酮)
|
PCL-#-Chp0110-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
3680-32-8 |
25mg
|
咨詢
|
咨詢 |
PCL |
西咪替丁雜質(zhì)Ⅰ 酰胺類似物([(甲胺基)[[2-[[5-甲基-1H-咪唑-4-基)甲基]硫]乙基]氨基]亞甲基]-尿素)
|
PCL-#-Chp0109-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
77076-18-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
西咪替丁雜質(zhì)Ⅰ 酰胺類似物([(甲胺基)[[2-[[5-甲基-1H-咪唑-4-基)甲基]硫]乙基]氨基]亞甲基]-尿素)
|
PCL-#-Chp0109-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
77076-18-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
地塞米松磷酸鈉注射液雜質(zhì)Ⅰ16α-甲基-11β,17α,21-三羥基-9α-氟-1β-磺酸基孕甾-4-烯-3,20-二銅-21-磷酸酯二鈉鹽
|
PCL-#-Chp0108-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0108-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
地塞米松磷酸鈉注射液雜質(zhì)Ⅰ16α-甲基-11β,17α,21-三羥基-9α-氟-1β-磺酸基孕甾-4-烯-3,20-二銅-21-磷酸酯二鈉鹽
|
PCL-#-Chp0108-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
PCL-#-Chp0108-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
地紅霉素雜質(zhì)Ⅱ 16S-地紅霉素異構(gòu)體;[(9S,16S)-9,11-e二脫氧-9,11-[亞氨基[(1R)2-(2-甲氧基乙氧基)亞乙基]氧]紅霉素
|
PCL-#-Chp0107-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
62013-04-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
地紅霉素雜質(zhì)Ⅱ 16S-地紅霉素異構(gòu)體;[(9S,16S)-9,11-e二脫氧-9,11-[亞氨基[(1R)2-(2-甲氧基乙氧基)亞乙基]氧]紅霉素
|
PCL-#-Chp0107-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
62013-04-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
地紅霉素雜質(zhì)Ⅰ9-(S)紅霉胺;(9S)-9-氨基-9-脫氧紅霉素
|
PCL-#-Chp0106-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
26116-56-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
地紅霉素雜質(zhì)Ⅰ9-(S)紅霉胺;(9S)-9-氨基-9-脫氧紅霉素
|
PCL-#-Chp0106-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
26116-56-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
吉非羅齊雜質(zhì)Ⅰ2,5-二甲基苯酚
|
PCL-#-Chp0105-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
95-87-4 |
50mg
|
咨詢
|
咨詢 |
PCL |
吉非羅齊雜質(zhì)Ⅰ2,5-二甲基苯酚
|
PCL-#-Chp0105-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
95-87-4 |
25mg
|
咨詢
|
咨詢 |
PCL |
對(duì)氨基水楊酸鈉雜質(zhì)Ⅱ 5-氨基水楊酸
|
PCL-#-Chp0104-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
89-57-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
對(duì)氨基水楊酸鈉雜質(zhì)Ⅱ 5-氨基水楊酸
|
PCL-#-Chp0104-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
89-57-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
對(duì)氨基水楊酸鈉雜質(zhì)Ⅰ間氨基酚
|
PCL-#-Am100-50mg
|
≥95% ,雜質(zhì)對(duì)照品 |
591-27-5 |
50mg
|
¥ 400.0
|
3-5天 |
PCL |
對(duì)氨基水楊酸鈉雜質(zhì)Ⅰ間氨基酚
|
PCL-#-Am100-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
591-27-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
加巴噴丁雜質(zhì)Ⅰ 2-氮雜螺[4,5]癸烷-3-酮
|
PCL-#-Chp0103-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
64744-50-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
加巴噴丁雜質(zhì)Ⅰ 2-氮雜螺[4,5]癸烷-3-酮
|
PCL-#-Chp0103-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
64744-50-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
尼群地平雜質(zhì)Ⅰ 2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸甲酯乙酯
|
PCL-#-Chp0102-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
89267-41-4 |
50mg
|
咨詢
|
咨詢 |
PCL |
尼群地平雜質(zhì)Ⅰ 2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二甲酸甲酯乙酯
|
PCL-#-Chp0102-25mg
|
≥95% 雜質(zhì)對(duì)照品 |
89267-41-4 |
25mg
|
咨詢
|
咨詢 |
PCL |
尼索地平雜質(zhì)Ⅱ 2,6-二甲基-4-(2-亞硝基苯基)-3,5-吡啶二羧酸甲酸甲酯異丁酯
|
PCL-#-Chp0101-50mg
|
≥95% 雜質(zhì)對(duì)照品 |
87375-91-5 |
50mg
|
咨詢
|
咨詢 |
PCL |